Cisatracurium Besylate
NDC Package 24584-1111-1
Package Information
Cisatracurium Besylate is a . Marketed by Piramal Healthcare Uk Limited, this product is identified by NDC 24584-1111 and is authorized under FDA application ANDA212432.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 24584 - Piramal Healthcare Uk Limited
- 24584-1111 - Cisatracurium Besylate
- 24584-1111-1 - 5 mL in 1 VIAL, SINGLE-DOSE
- 24584-1111 - Cisatracurium Besylate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 24584-1111-1 identifies a specific commercial package of 5 ml in 1 vial, single-dose of Cisatracurium Besylate, labeled by Piramal Healthcare Uk Limited. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Piramal Healthcare Uk Limited on August 01, 2022. The current certification is valid through January 28, 2026.
How is this Piramal Healthcare Uk Limited product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 24584111101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.